Member Info for Jace86

Wid - it has been explained many times that big investors have risk alignments to adhere to.

They ultimately won't unless the mcap is at a certain level. There will be other indicators too that they will have to adhere to.

This is why retail makes massive gains in the right shares when they are bottomed. Retail can have significant advantages.

Letsgo - it's getting sold into because the material news of developed test, trial, approval marker is yet to be done.

If good enough, trade it but most lose doing this.

If patient enough, accumulate and hold.

10p will be laughable should we see the test go live.

And yet you are still here hoping it does...

I'm not exactly sure Ian. I can only assume fed up PI that can't sit on their hands and went off to chase other rainbows because a person with a random avatar on twitter told them it's going to the moon.

Have a great New Year and to everyone else too!

Yes CC.

I've lost count of how often I've said it's not a share to trade. A handful might do well from it but you have to be Infront of a screen all day everyday for a chance to get it to work for you.

It's a share to build a position in. People aren't understanding that where we are so far is the final lap in a very long grand prix.

All it takes is these MABs to be optimised and then these will be in a very short trial and off we go.

I'm really not bothered about the price as I see opportunity down here and actually hope it stays here for a few more months to build an even larger position. Yes, I'm being greedy.

I'm not interested in a mere bag, I'm not looking for a return to IPO price. I'm looking far far beyond that.

As I've said, this is worth billions. I'll be retiring and will do so knowing I've helped fund this work too from the BOU days, not just bought open market.

I kept my holding from the float and continued to add to it.

I could see the upside then and still see it now. Even more so.

As for PR, does it need it?

Unless you are after a quick trade and a pump to dump at a minor profit maybe.

Combination of fed up BOU holders and then I have my own reservations on who took placings etc then we can see why the price went down.

The partnerships we have will be worth far more than any AIM style PR. (I know we aren't aim but it's the typical thing down here).

I think 2023 will be a good year. I'll continue to add when and where I can, certainly whilst the price is here.

I suspect I'll be retiring from this share...

Hi smeeno

I think patients would be profiled for being at risk. Whether this be smoking status or working environment. Particularly for China and it wouldn't surprise me if this is mandated in some way.

For the US, it may even form part of an insurance obligation to undergo some kind of screening if deemed at risk. Or it may be incentivised to take up a test to reduce premiums etc.

Just my thoughts...

We aren't immediately aiming for an Elisa test. It would be lab based screening first.

Elisa test is further down the line.

We have hinted at broadening out to other cancers.

With what we know about the grail test too, it's simply unspecific and from their own data looks too unreliable.

Anyway, I know why I'm here. I know what my expectations are. We all have different ones and that's what makes a market.

Might not be what it is charging the NHS but perhaps a rough idea...

https://www.science.org/content/article/complexities-are-staggering-u-s-plans-huge-trial-blood-tests-multiple-cancers

We can only wait and see.

We have been told the target. I can't expect that it is a random figure plucked from thin air.

Someone would have calculated value somewhere I expect that value is better defined in Neil's post a few down.

What I don't know is how expensive the process is behind producing the materials for our test Vs others. This would give any of us the ability to compare but as I say, I think the company would have already factored this in.

How much are Grail charging the NHS currently, do we know per test...?

Look at the RNS from 3 Feb. Price target quoted.

"Get minted with Vinted"

:)

Those being conservative...

Consider what a pipeline may be worth to an entity much much larger...

It's why whenever I can, I add. Probably got similar results to me...

China alone 30,000,000 tests per year.

Royalty of 10 per go.

For 20 times current mcap they could FO.

I've said it before and will say again. It's worth billions.

Now imagine monoclonal antibody and protein therapy treatments.... Eventually instead of chemo...

That's where this leads. Why forcibly mutate someone when you can correct the protein expressions themselves?

Widglide. Contrary views are fine if they contain information.

The problem with your posts is that they repeat the same lines because of your emotion towards the initial listing price.

And then we see the line of no progress yet the complete opposite is true.

The company cannot control where the price went since listing. Market manipulation and fed up holders whilst the share was suspended was the problem.

The rest of us perhaps see opportunity down here and have been wise enough to significantly average down at lower levels.

I still fail to see why you never cut and ran and used the lesson to tailor your strategies going forward.

There's literally medical conferences every other week...

I wonder how many biotech and life science firms there are all over the world that will have more important things to be doing instead of having an expensive wine and dine session...?

Incase you haven't noticed, the big firms don't buy small. They take the risk away by letting funders pay for the research and then buy out a viable company and its products and pipeline.

This is why you see pharma's being snapped up for billions. Not 10 or 20 mil.

Things are heading in the right direction here. It's why I continue to add where possible.

Things don't happen overnight. I think people have become used to the nonsense from COVID where up pops a sudden vaccine without adequate testing and questionable outcomes...

Things here have been so far getting some properly.

Bored PIs and traders that only care about a chart...

Same smokey.

I continue to hold and add.

I believe the interest and change in the register is of significance.